Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 75, Issue 1, 2006, Pages 25-31

  Kumar, Sekar Ashok ^a   Sudhahar, Varatharajan ^a   Varalakshmi, Palaninathan ^a  

^a Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CARBONYL DERIVATIVE; CHOLESTEROL; CHOLIC ACID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID THIOCTIC ACID DERIVATIVE; LACTATE DEHYDROGENASE; LIPOPROTEIN; MALONALDEHYDE; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG DOSE REGIMEN; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; HYPERCHOLESTEROLEMIA; KIDNEY DISEASES; LIPID METABOLISM; LIPID PEROXIDATION; LIPOPROTEINS; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; THIOCTIC ACID;

RATTUS NORVEGICUS;

EID: 33746058991     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.04.004     Document Type: Article

References (39)

1. Vazquez-Perez S., Aragoncillo P., de Las Heras N., Navarro-Cid J., Cediel E., Sanz-Rosa D., Ruilope L.M., Diaz C., Hernandez G., Lahera V., and Cachofeiro V. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrol. Dial. Transplant. 16 Suppl. 1 (2001) 40-44
2. Moorhead J.F., Chan M.K., El-Nahas M., and Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2 8311 (1982) 1309-1311
3. Bentley M.D., Rodriguez-Porcel M., Lerman A., Sarafov M.H., Romero J.C., Pelaez L.I., Grande J.P., Ritman E.L., and Lerman L.O. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int. 61 3 (2002) 1056-1063
4. Chade A.R., Rodriguez-Porcel M., Grande J.P., Krier J.D., Lerman A., Romero J.C., Napoli C., and Lerman L.O. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106 9 (2002) 1165-1171
5. Napoli C., and Lerman L.O. Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin. Proc. 76 6 (2001) 619-631
6. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91 6 (1993) 2546-2551
7. Hazra A., Tripathi S.K., and Ghosh A. Pharmacology and therapeutic potential of the n-3 polyunsaturated fatty acids, eicosapentaenoic acid and docosohexaenoic acid in fish oil. Ind. J. Pharmacol. 31 (1999) 247-264
8. Wheeler D.C., Nair D.R., Persaud J.W., Jeremy J.Y., Chappell M.E., Varghese Z., and Moorhead J.F. Effects of dietary fatty acids in an animal model of focal glomerulosclerosis. Kidney Int. 39 5 (1991) 930-937
9. Somani S.M., Husain K., Whitworth C., Trammell G.L., Malafa M., and Rybak L.P. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol. Toxicol. 86 5 (2000) 234-241
10. Midaoui A.E., Elimadi A., Wu L., Haddad P.S., and de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am. J. Hypertens. 16 3 (2003) 173-179
11. Baydas G., Yilmaz O., Celik S., Yasar A., and Gursu M.F. Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch. Med. Res. 33 6 (2002) 515-519
12. 2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. Free Radic. Biol. Med. 25 3 (1998) 287-297
13. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., and Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332 8 (1995) 488-493
14. Lenin M., Thiagarajan A., Nagaraj M., and Varalakshmi P. Attenuation of oxalate-induced nephrotoxicity by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental rat model,. Prostaglandins Leukot. Essent. Fatty Acids 65 5-6 (2001) 265-270
15. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 2 (1992) 227-231
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Shigenaga M.K., Lee H.H., Blount B.C., Christen S., Shigeno E.T., Yip H., and Ames B.N. Inflammation and NO(X)-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc. Natl. Acad. Sci. USA 94 7 (1997) 3211-3216
18. Hogberg J., Larson R.E., Kristoferson A., and Orrenius S. NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem. Biophys. Res. Commun. 56 (1974) 836-842
19. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186 (1990) 464-478
20. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J Lab. Clin. Med. 82 3 (1973) 473-482
21. R. Fried, L.W. Fried, Xanthine oxidase (Xanthine dehydrogenase), In Bergmeyer. Methods of Enzymatic Analysis, vol. 2. Academic Press, New York, 1966, pp. 644-650.
22. King J. Practical clinical enzymology. In: Van D. (Ed). The Dehydrogenases or Oxidoreductases-Lactate Dehydrogenase (1965), Nostrand Company Limited, London 83-93
23. King J. Practical clinical enzymology. In: Van D. (Ed). The Hydrolases-acid and Alkaline Phosphatase (1965), Nostrand Company Limited, London 191-208
24. Kumar S.A., Sudhahar V., and Varalakshmi P. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia. Clin. Chim. Acta 355 (2005) 197-204
25. Gesquiere L., Loreau N., Minnich A., Davignon J., and Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic. Biol. Med. 27 (1999) 134-145
26. Peric-Golia L., and Peric-Golia M. Aortic and renal lesions in hypercholesterolemic adult, male, virgin sprague-dawley rats. Atherosclerosis 46 1 (1983) 57-65
27. Wilson S.H., Chade A.R., Feldstein A., Sawamura T., Napoli C., Lerman A., and Lerman L.O. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol. Dial. Transplant. 18 4 (2003) 703-709
28. Kohno M., Yasunari K., Minami M., Kano H., Maeda K., and Yoshikawa J. Suppression by eicosapentaenoic acid of oxidized low-density lipoprotein and lysophosphatidylcholine-induced migration in cultured rat vascular smooth muscle cells. Metabolism 49 5 (2000) 560-562
29. Jeyarajah D.R., Kielar M., Penfield J., and Lu C.Y. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro. J. Surg. Res. 83 2 (1999) 147-150
30. Takahashi M., Tsuboyama-Kasaoka N., Nakatani T., Ishii M., Tsutsumi S., Aburatani H., and Ezaki O. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am. J. Physiol. Gastrointest. Liver Physiol. 282 2 (2002) G338-G348
31. Cao Z., Tsang M., Zhao H., and Li Y. Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury. Biochem. Biophys. Res. Commun. 310 3 (2003) 979-985
32. Biewenga G.P., Haenen G.R., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 3 (1997) 315-331
33. Berliner J.A., and Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20 5 (1996) 707-727
34. Rubbo H., Darley-Usmar V., and Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9 5 (1996) 809-820
35. Hsieh C.C., Yen M.H., Yen C.H., and Lau Y.T. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. 49 1 (2001) 135-145
36. Kagan V.E., Serbinova E.A., Forte T., Scita G., and Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33 3 (1992) 385-397
37. Erdogan H., Fadillioglu E., Ozgocmen S., Sogut S., Ozyurt B., Akyol O., and Ardicoglu O. Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostaglandins Leukot. Essent. Fatty Acids 71 3 (2004) 149-152
38. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
39. Naik S.R., and Sheth U.K. Studies on two new derivatives of N-aralkyl-o-ethoxybenzamides: Part II-Biochemical studies on their anti-inflammatory activity. Indian J. Exp. Biol. 16 11 (1978) 1175-1179